Benzinga | Aug 18, 2020 06:08AM EDT

Cowen & Co. Initiates Coverage On Inozyme Pharma with Outperform Rating

Cowen & Co. analyst Marc Frahm initiates coverage on Inozyme Pharma (NASDAQ:INZY) with a Outperform rating.